These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. [The passive hemagglutination test for detection of antibodies to scarlet fever toxin]. Silich VA; Fiks LI; Cherkasskaia RS Zh Mikrobiol Epidemiol Immunobiol; 1972 Aug; 49(8):57-62. PubMed ID: 4673601 [No Abstract] [Full Text] [Related]
27. Purification and characterization of erythrogenic toxins. II. Communication: in vivo biological activities of erythrogenic toxin produced by streptococcus pyogenes strain ny-5. Hríbalová V; Knöll H; Gerlach D; Köhler W Zentralbl Bakteriol A; 1980; 248(3):314-22. PubMed ID: 7013358 [TBL] [Abstract][Full Text] [Related]
28. Isolation and characterization of a mitogen characteristic of group A streptococci (Streptococcus pyogenes). Gerlach D; Günther E; Köhler W; Vettermann S; Fleischer B; Schmidt KH Zentralbl Bakteriol; 1995 Jan; 282(1):67-82. PubMed ID: 7734831 [TBL] [Abstract][Full Text] [Related]
29. Tissue cages for study of experimental streptococcal infection in rabbits. II. Humoral and cell-mediated immune response to erythrogenic toxins. Knöll H; Holm SE; Gerlach D; Kühnemund O; Köhler W Immunobiology; 1985 Mar; 169(2):116-27. PubMed ID: 3997195 [TBL] [Abstract][Full Text] [Related]
30. Streptococcal superantigens and the return of scarlet fever. Hurst JR; Brouwer S; Walker MJ; McCormick JK PLoS Pathog; 2021 Dec; 17(12):e1010097. PubMed ID: 34969060 [TBL] [Abstract][Full Text] [Related]
31. [Study of the immunological and epidemiological activity of purified sorbed scarlet fever toxin]. MITEL'MAN SL Zh Mikrobiol Epidemiol Immunobiol; 1960 Aug; 31():70-5. PubMed ID: 13771373 [No Abstract] [Full Text] [Related]
32. [Relationship between anti-streptokinase levels and hemolytic streptococcal types in scarlet fever]. Shimizu H; Iimura T; Yagishita N; Nagase K Kansenshogaku Zasshi; 1973 Dec; 47(12):522-3. PubMed ID: 4208601 [No Abstract] [Full Text] [Related]
33. [Serological study on scarlet fever]. Nakamizo Y; Tsuji S; Shimizu H Kansenshogaku Zasshi; 1973 Dec; 47(12):519-21. PubMed ID: 4208600 [No Abstract] [Full Text] [Related]
34. THE ROLE OF TEMPERATE BACTERIOPHAGE IN THE PRODUCTION OF ERYTHROGENIC TOXIN BY GROUP A STREPTOCOCCI. ZABRISKIE JB J Exp Med; 1964 May; 119(5):761-80. PubMed ID: 14157029 [TBL] [Abstract][Full Text] [Related]
35. [Relationship of type specific M antigen content, streptolysin O titer, serological M type and proteinase production of group A streptococci isolated from the patients of scarlet fever (author's transl)]. Kobayashi S; Hamada A Kansenshogaku Zasshi; 1982 Jan; 56(1):20-5. PubMed ID: 6177808 [No Abstract] [Full Text] [Related]
37. [Streptococcal erythrogenic toxin as a nonspecific sensitizer of the animal organism]. Anatoliĭ SA; Iunusova MI; Shapiro NI; Vasil'eva TG Tr Inst Im Pastera; 1982; 57():65-7. PubMed ID: 7170738 [No Abstract] [Full Text] [Related]
38. [Induction of immune interferon by erythrogenic toxins A and B from Streptococcus pyogenes]. Tonew E; Gerlach D; Tonew M; Köhler W Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Sep; 252(4):463-71. PubMed ID: 6817542 [TBL] [Abstract][Full Text] [Related]
39. [Virulent and toxigenic properties of beta-hemolytic streptococci in relation to the scarlatina epidemic process]. Gladkova KK; Dodonov VN; Bliumental' KV; Cherkasskaia RS; Severov AM Zh Mikrobiol Epidemiol Immunobiol; 1973 Jul; 50(7):24-7. PubMed ID: 4272990 [No Abstract] [Full Text] [Related]
40. Mitogenic activity of extracellular cationic products produced by group A streptococci; analysis of the lymphocyte response. Suzuki M; Vogt A Clin Exp Immunol; 1986 Oct; 66(1):132-8. PubMed ID: 3542316 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]